SEC Company Response from NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Oct 10, 2006
NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: Oct. 10, 2006 · CIK: 0001072379 · Accession: 0000891020-06-000272
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-134320
Letter
Re: 58,969,641 Shares Northwest Biotherapeutics, Inc. Common Stock Registration No. 333-134320
<PAGE> [NORTHWEST BIOTHERAPEUTICS, INC. LETTERHEAD]
October 10, 2006
Securities and Exchange Commission 450 Fifth Street NW Washington, DC 20549 Attn: Jeffrey P. Riedler, Assistant Director
Ladies and Gentlemen:
Pursuant to the provisions of Rule 461 promulgated under the Securities Act of 1933, as amended (the `Securities Act"), Northwest Biotherapeutics, Inc., a Delaware corporation (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-1 (File No. 333-134320) be accelerated to, and that the Registration Statement be declared effective by 3:00 p.m. Eastern Daylight Time on October 10, 2006 or as soon thereafter as practicable.
The Company hereby acknowledges that:
o should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
o the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
o the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The Company is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the public offering of the securities specified in the Registration Statement.
Sincerely,
/s/ Alton Boynton
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
<PAGE>
[NORTHWEST BIOTHERAPEUTICS, INC. LETTERHEAD]
October 10, 2006
Securities and Exchange Commission
450 Fifth Street NW
Washington, DC 20549
Attn: Jeffrey P. Riedler, Assistant Director
Re: 58,969,641 Shares
Northwest Biotherapeutics, Inc. Common Stock
Registration No. 333-134320
Ladies and Gentlemen:
Pursuant to the provisions of Rule 461 promulgated under the Securities Act of
1933, as amended (the `Securities Act"), Northwest Biotherapeutics, Inc., a
Delaware corporation (the "Company") hereby requests that the effective date of
the Company's Registration Statement on Form S-1 (File No. 333-134320) be
accelerated to, and that the Registration Statement be declared effective by
3:00 p.m. Eastern Daylight Time on October 10, 2006 or as soon thereafter as
practicable.
The Company hereby acknowledges that:
o should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;
o the action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not relieve the
Company from its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and
o the Company may not assert staff comments and the declaration of
effectiveness as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.
The Company is aware of its responsibilities under the Securities Act and the
Securities Exchange Act of 1934, as amended, as they relate to the public
offering of the securities specified in the Registration Statement.
Sincerely,
/s/ Alton Boynton
Alton Boynton, President
[NORTHWEST BIOTHERAPEUTICS, INC. LETTERHEAD BOTTOM]
</TEXT>
</DOCUMENT>